Hyperion Clal Biotech

Hyperion Clal Biotech - Psychology, Special Needs, Health - Posted: 8th Oct, 2014 - 12:30am

Text RPG Play Text RPG ?
 

Posts: 1 - Views: 370
Biotechnology News
Post Date: 8th Oct, 2014 - 12:30am / Post ID: #

Hyperion Clal Biotech

Hyperion Clal Biotech Resolve Dispute Over Diabetes Drug
Biotechnology News

JERUSALEM (Reuters) - Hyperion Therapeutics and Clal Biotechnology Industries said they agreed to resolve their dispute after Hyperion halted development of a diabetes drug it bought from Clal due to manipulation of trial data. Hyperion had bought Israel's Andromeda Biotech - which is developing DiaPep277, a treatment for Type I diabetes that is undergoing a second advanced clinical study - from Clal for $12.5 million in June. The deal included milestone payments reaching $570 million. But in September, U.S. ...
Source

Sponsored Links:

 
> TOPIC: Hyperion Clal Biotech
 

▲ TOP


International Discussions Coded by: BGID®
ALL RIGHTS RESERVED Copyright © 1999-2024
Disclaimer Privacy Report Errors Credits
This site uses Cookies to dispense or record information with regards to your visit. By continuing to use this site you agree to the terms outlined in our Cookies used here: Privacy / Disclaimer,